Watson Pharmaceuticals searches for two new presidents

Share this article:
Watson Pharmaceuticals announced it has initiated a search for two newly created president positions for each of the Corona, Calif.-based company's business units – brands and generics.
As a result of this new management structure, Joseph Papa, Watson's chief operating officer and president, will leave the company Nov. 19.
"Following our decision in June to focus on generics and specialty brand products, including urology and nephrology, we have continued to implement strategies to increase our focus in these specialty areas," said Allen Chao, Watson's chief executive. "We believe having a president in each business unit will enhance our ability to maximize the growth of each business."
Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union